[2]National Institute for Health and Care Excellence, Semaglutide for Managing Overweight and Obesity, nice.org.uk Novo Nordisk is currently testing 25 mg and 50 mg oral doses to close the efficacy gap without injections, with Phase III readouts expected in late 2026
It was developed back in 2012, as a treatment for people with type 2 diabetes, but it took almost 5 years before it was FDA-approved for use
This applies to all eligible patients (View medical requirements) Access to Affordable GLP-1 Medication Eligible patients receive access to affordable GLP-1 medication
If a pen or vial was left out, overheated, or frozen, rely on the written label and the dispensing pharmacy rather than guesswork
Your choice depends on your goals and medical profile
Like Wegovy and Trulicity, Ozempic belongs to a class of drugs known as glucagon-like peptide-1 agonists, or GLP-1 receptor agonists